Alison Bigley
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cell Biology top 5%
- Microtubule and mitosis dynamics
Papers in
-
- Angiogenesis and VEGF in Cancer 5
- Metabolism, Diabetes, and Cancer 2
- Oncology 6
- HER2/EGFR in Cancer Research 2
- Co-authors
- Stephen R. Wedge (3 shared papers)Kevin J. Randall (3 shared papers)F. Russell Westwood (2 shared papers)Jane Kendrew (5 shared papers)Robert C. Scott (2 shared papers)Laurent Hennequin (2 shared papers)Rosemary Chester (1 shared paper)Gareth Hughes (1 shared paper)
- Journals
- Toxicologic Pathology (5 papers)Clinical Cancer Research (2 papers)Laboratory Investigation (1 paper)International Journal of Experimental Pathology (1 paper)Journal of Histochemistry & Cytochemistry (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Alison Bigley
20 papers receiving 1.3k citations
Alison Bigley's Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 450
- Cell Biology 255
- Cancer Research 158
- Molecular Biology 654
- Endocrinology, Diabetes and Metabolism 111
Countries citing papers authored by Alison Bigley
This map shows the geographic impact of Alison Bigley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Bigley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Bigley more than expected).
Fields of papers citing papers by Alison Bigley
This network shows the impact of papers produced by Alison Bigley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Bigley. The network helps show where Alison Bigley may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison Bigley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. Hit paper breakdown → | 2002 | 702 |
| 2 | 2007 | 281 | |
| 3 | 2005 | 151 | |
| 4 | 2010 | 54 | |
| 5 | 2004 | 44 | |
| 6 | 2008 | 37 | |
| 7 | 2016 | 28 | |
| 8 | 2013 | 18 | |
| 9 | 2014 | 14 | |
| 10 | 2009 | 8 | |
| 11 | 2005 | 8 | |
| 12 | 2014 | 7 | |
| 13 | The VEGF receptor tyrosine kinase inhibitor AZD2171 inhibits VEGF signaling, angiogenesis, and tumor growth in vivo | 2004 | 7 |
| 14 | 2012 | 5 | |
| 15 | 2008 | 5 | |
| 16 | 2016 | 5 | |
| 17 | 2017 | 2 | |
| 18 | 2022 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2016 | 1 |
About Alison Bigley
Alison Bigley is a scholar working on Molecular Biology, Oncology, Surgery, Cell Biology and Immunology, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (5 papers), Diabetes and associated disorders (2 papers), Metabolism, Diabetes, and Cancer (2 papers), HER2/EGFR in Cancer Research (2 papers), Pancreatic function and diabetes (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Optical Imaging and Spectroscopy Techniques (1 paper). The work is most often cited by research in Oncology (450 citations), Cell Biology (255 citations), Cancer Research (158 citations), Molecular Biology (654 citations) and Endocrinology, Diabetes and Metabolism (111 citations). Alison Bigley has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Stephen R. Wedge, Kevin J. Randall, F. Russell Westwood, Jane Kendrew, Robert C. Scott, Laurent Hennequin, Rosemary Chester, Gareth Hughes, Elaine S. E. Stokes and Helen Musgrove. Their work appears in journals such as Toxicologic Pathology, Clinical Cancer Research, Laboratory Investigation, International Journal of Experimental Pathology and Journal of Histochemistry & Cytochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.